Clinical Scorecard: AI-Enhanced CT Imaging Model for Improved Diagnosis of Pancreatic Cystic Neoplasms: Development, Validation, and Clinical Implications Across Multiple Centers

At a Glance

Key Highlights

• PCN-AI significantly improves radiologists’ diagnostic accuracy (AUC increase from 0.786 to 0.845) and reduces interpretation time by 23.7%.
• Hierarchical classification distinguishes mucinous vs. non-mucinous PCN, precancerous vs. malignant lesions, and differentiates key subtypes (IPMN, MCN, SCN, SPN).
• Real-world implementation shows PCN-AI outperforms double-reading, correctly identifying missed malignant cases and reducing clinical workload by 39.3%.

Guideline-Based Recommendations

Diagnosis

• Use contrast-enhanced CT imaging with AI-assisted analysis to improve accuracy in PCN subtype classification.
• Incorporate hierarchical classification to differentiate mucinous from non-mucinous PCN and identify malignancy risk aligned with WHO criteria.
• Apply AI models to reduce inter-observer variability and enhance detection of high-risk features beyond conventional size and duct dilation thresholds.

Management

• Utilize AI-assisted diagnosis to enable timely intervention for malignant PCN cases missed by conventional double-reading.
• Integrate AI recommendations into radiologist workflows to improve diagnostic efficiency and precision management.

Monitoring & Follow-up

• Monitor changes in pancreatic duct dilation with anatomical specificity and growth rate as per updated evidence to assess malignancy risk.
• Use AI-derived quantitative imaging biomarkers for consistent follow-up and risk stratification.

Risks

• Be aware of limitations in manual quantification and subjective interpretation leading to diagnostic variability.
• Consider false-negative rates and complications associated with invasive procedures like EUS-FNA when relying on non-invasive imaging.

Patient & Prescribing Data

1835 patients with pancreatic cystic neoplasms from multiple centers, mean age 54 years, majority female

AI-assisted CT diagnosis improved detection of malignant PCN, enabling earlier intervention and reducing radiologist workload; high acceptance of AI recommendations (87.14%) supports clinical integration.

Clinical Best Practices

• Adopt AI-enhanced CT imaging models for comprehensive, quantitative assessment of PCN to improve diagnostic accuracy and consistency.
• Implement hierarchical classification frameworks to guide clinical decision-making based on subtype and malignancy risk.
• Incorporate AI tools into radiologist workflows to reduce interpretation time and workload while maintaining diagnostic quality.
• Validate AI models across multiple centers and real-world cohorts to ensure robustness and generalizability.
• Align imaging interpretation with updated clinical criteria including anatomical specificity of duct dilation and growth rates.

References

• Pancreatic cancer survival and epidemiology
• WHO diagnostic criteria for pancreatic cystic neoplasms
• Clinical guidelines on pancreatic cystic neoplasm management